OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	5/31/2006 1:34:08 PM
	of 447

Colin Goddard: There's an outstanding question, one that absolutely fascinates me. The presentations where you used to crow about two IND-track projects, the OSI project for asthma and the Solvay project for CHF, are documented here at SI. As SLV320 was advancing at Solvay, why did you suddenly go silent about the adenosine receptor program in general, and re. SLV320 in particular? What am I missing? You went silent "pre-angio, pre-IMCL, etc." at a point where the stock needed goosing, so it's not like you'd have forgotten about a chunk of CHF. Thanks, in advance, for any answer. Your 10-K filings have been insufficient. These projects went poof. This persisting policy of silence on this front is sore thumb stuff. You're downright weird here. There are now multiple confirmations that SLV320 is in human phase II testing. It was YOUR crowing about the projects that set my heart aflutter. You not only stopped crowing at a time where your business plan was floundering, but you've NEVER mentioned the projects again. Why? Sore thumb. Richard Harmon

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next